Navigation Links
Scan Technology Tied to Overtreatment of Clots in Lungs
Date:5/9/2011

MONDAY, May 9 (HealthDay News) -- Overdiagnosis and overtreatment of pulmonary embolism is a problem in the United States due to the large increase in the use of computed tomography pulmonary angiography (CTPA), a new study suggests.

A pulmonary embolism (PE) is a potentially life-threatening blood clot in the lungs. CTPA was introduced in 1998 to improve detection of PE and its use has grown rapidly, according to background information in the study by Boston University School of Medicine researchers.

The investigators compared data about PE in U.S. adults before (1993-1998) and after (1998-2006) CTPA was introduced, and found that the incidence of PE increased 81 percent after CTPA became available, from 62.1 to 112.3 per 100,000 people.

Deaths from PE decreased during both time periods, but more so before (8 percent reduction, from 13.4 to 12.3 per 100,000), than after the introduction of CTPA (3 percent reduction, from 12.3 to 11.9 per 100,000 people), the research team reported.

There was also a slight improvement in case fatality before CTPA (8 percent decrease, from 13.2 to 12.1 percent of patients) and a substantial improvement after CTPA (36 percent decrease, from 12.1 to 7.8 percent of cases), according to the report published in the May 9 issue of the Archives of Internal Medicine.

While CTPA offers many benefits, the downside is that it can detect clots so small that they might never cause symptoms or death, yet the treatment for these clots, known as anti-clotting therapy, may be harmful to patients, the researchers said.

"Overdiagnosis matters because it can lead to [treatment-related] harm. While a clinically insignificant PE is by definition not harmful, treating such an embolism can cause harm such as bleeding from anticoagulation [anti-clotting therapy], which can -- in the worst case -- be fatal," lead author Dr. Renda Soylemez Wiener, an assistant professor of medicine, said in a university news release.

The frequency of presumed complications of anticoagulation for PE was stable before CTPA, but increased 71 percent (from 3.1 to 5.3 per 100,000) after CTPA became available, the study authors explained.

The problem of overdiagnosis and overtreatment of PE is likely to continue to grow, according to the study authors. They called for further research to determine whether some PE patients with small clots can safely forgo anticoagulation treatment.

More information

The Society for Vascular Surgery has more about pulmonary embolism.

-- Robert Preidt

SOURCE: Boston University Medical Center, news release, May 9, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Three NHS Trusts Choose BigHand Voice Technology Under YHCPC Framework Agreement
2. Gold at Forefront of Nanotechnology Revolution
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. Embark Health Selects the Jellyvision Lab's Interactive Conversation Technology to Educate Website Visitors on Advance Directives
5. First Breakthrough in Water Heating Technology!
6. New Technology Could Widen Reach of Vaccines
7. WebMD to Present at the Goldman Sachs Technology and Internet Conference 2010
8. Nanotechnology could help Arab region
9. Genetic health risks in children of assisted reproductive technology
10. Mennen Medical Launches the VitaLogik 6000, a Pre-Configured Multi-Parameter Patient Monitor with New High Performance Wireless Technology
11. New cardiac CT technology drastically reduces patient radiation exposure
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Scan Technology Tied to Overtreatment of Clots in Lungs
(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may be commonplace ... injury, it occurs when the muscles around the pelvis become inflamed. Over time, ... lower torso, as well as accompanying tenderness and weakness. Without proper intervention, it ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... epigenetic research products enables researchers to pursue the recent RNA methylation “gold rush” ... . In light of the newfound characteristics of N6-methyladenosine, or m6A , ...
(Date:3/27/2017)... ... March 27, 2017 , ... Janet Schloz is still in shock after receiving a $2,500 ... had in a long time,” she said. , She thinks the coming week is going ... never thought I would have to help my students.” , The award will allow the ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017  Cryoport, Inc. (NASDAQ: CYRX, ... intends to offer shares of common stock in an ... on file with the Securities and Exchange Commission (the ... conditions, and there can be no assurance as to ... as to the actual size or terms of the ...
(Date:3/27/2017)... 2017 To mark the end of Save Your ... leader in digital imaging solutions, will showcase Canon eye care ... New York,s Jacob Javits Center from ... sponsored by the American Optometric Association, is observed annually in ... comprehensive eye exams. In recognition of this observance, Canon ...
(Date:3/27/2017)... March 27, 2017  Sophiris Bio Inc. (NASDAQ: ... a clinical late-stage biopharmaceutical company developing topsalysin (PRX302) ... today reported fourth quarter and full year 2016 ... Key Corporate Highlights: Advanced ... Cancer. During 2016, the Company reported successful results ...
Breaking Medicine Technology: